be filed with the Securities and Exchange Commission and in our other filings with the Securities and Exchange Commission. Prostate Cancer Intervention versus Observation Trial (pivot) Study Group, authors. Ankerst DP, Hoefler J, Bock S,. These men could have safely avoided a prostate biopsy, and with continued monitoring, would have further lowered their long-term risk. Siegel RL, Miller KD, Jemal. Benchikh A, Savage C, Cronin A,. Barry MJ, Gallagher PM, Skinner JS, Fowler., Jr Adverse effects of robotic-assisted laparoscopic versus open retropubic radical prostatectomy among a nationwide random sample of Medicare-age men.
643.Spratt,.E.,. The criteria most often published include: Gleason 6, when specified 2-3 positive cores with 50 cancer involvement in every positive core, a clinical T1c or T2a, a PSA 10 ng/mL and a PSA density.15 ng/mL/cc 324, 496. Low 42 intermediate 10 high 7 data missing 35-40 Gy/4-5 fx (8 sbrt-boost.5-21.8 Gy/3 fx after 45-50 Gy ebrt) ffbf 92 at 2 yr 99 low risk 97-85 intermediate 87 high risk Katz,. A PSA change (especially a PSA-DT three years) is a less powerful indicator to change management based on its weak link with grade progression 520, 521. 220.Hoedemaeker,.F.,.